Stock & Company Details
Arbutus Biopharma Corp $ABUS
Price:
N/A
N/A
198M
$1B
52 Week High:
N/A
10 Day Average Volume:
N/A
6.16
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
ABUS technical indicators
Latest Arbutus Biopharma Corp (ABUS) indicator readings as of 2026-08-28.
ABUS's 14-day RSI is 60.2, in neutral territory. At $5.07 it is trading 13.2% above its 200-day moving average of $4.48, and above its 50-day average of $4.69. Price sits in the middle of its Bollinger Bands ($4.25 to $5.35). ADX reads 26.0, indicating a trending market.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. It is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.
Finance Bot
Ask your questions
Start by typing a question below.
